Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " June 06, 2007":" July 06, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Highly active antiretroviral treatment (HAART)
22 Terminated
Has Results
Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay
Condition: HIV Infections
Interventions: Drug: maraviroc;   Procedure: Trofile Assay and HIV RNA quantification assay
23 Completed
Has Results
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
Condition: HIV Infections
Interventions: Procedure: Early Initiation of Highly Active Anti-Retroviral Therapy;   Procedure: Standard Care
24 Terminated
Has Results
A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV;   Drug: Integrase inhibitor
25 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
26 Completed Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
Conditions: Tuberculosis;   Aids;   Hiv Infections
Interventions: Drug: Nevirapine based therapy;   Drug: Efavirenz based therapy;   Drug: Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)
27 Completed
Has Results
A Phase 2 Study Of PF-00232798 In HIV Positive Patients
Condition: HIV
Intervention: Drug: PF-00232798

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-27) Next Page   
Indicates status has not been verified in more than two years